By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To Treat Heart Failure 3/31/2015 6:31:24 AM
Capricor Therapeutics, Inc. To Present At 3rd Annual Regen Med Investor Day On March 25, 2015 In New York 3/23/2015 9:22:34 AM
Capricor Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial & Business Highlights 3/19/2015 8:30:58 AM
Capricor Therapeutics, Inc. To Hold Fourth Quarter 2014 Business Update Conference Call On March 18, 2015 At 4:30 P.M. EDT 3/12/2015 7:47:36 AM
Capricor Therapeutics, Inc. To Present At The 27th Annual ROTH Conference 3/10/2015 7:56:11 AM
Capricor Therapeutics, Inc. Announces Uplisting To NASDAQ Capital Market 3/5/2015 9:32:18 AM
Capricor Therapeutics, Inc. Announces Enrollment Of Its Phase II Clinical Trial For Cenderitide To Treat Heart Failure 3/5/2015 7:22:00 AM
Capricor Therapeutics, Inc. Appoints Thomas Copmann, Ph.D. As Vice President Of Regulatory Affairs And Drug Development 2/27/2015 7:43:02 AM
Capricor Therapeutics, Inc. Announces $7 Million Private Placement Of Common Stock 2/4/2015 7:44:58 AM
Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On January 21, 2015 At 3:00 P.M. ET 1/21/2015 7:40:59 AM
1234
//-->